Workflow
公司治理
icon
Search documents
福蓉科技: 董事会提名委员会议事规则
Zheng Quan Zhi Xing· 2025-08-26 16:24
Core Points - The article outlines the governance structure and operational rules for the Nomination Committee of Sichuan Furong Technology Co., Ltd, emphasizing the importance of a scientific and democratic process in the nomination and appointment of directors and senior management. Group 1: General Provisions - The company establishes a Nomination Committee under the Board of Directors to enhance governance and optimize the composition of the board and management [1][2] - The resolutions made by the Nomination Committee must comply with relevant laws, regulations, and the company's articles of association [2][3] Group 2: Composition of the Committee - The Nomination Committee consists of three directors, with independent directors making up more than half of the committee [4] - The committee is chaired by an independent director, elected by the committee members and approved by the Board [5] Group 3: Responsibilities and Authority - The Nomination Committee is responsible for proposing candidates for directors and senior management, evaluating their performance, and making recommendations for replacements [11][12] - The committee must conduct thorough searches for qualified candidates and ensure compliance with legal and regulatory requirements [13][14] Group 4: Meeting Procedures - The Nomination Committee must hold at least one regular meeting each fiscal year, with additional temporary meetings as needed [8][9] - Meeting notifications must include essential details such as time, location, agenda, and contact information [9][10] Group 5: Voting and Decision-Making - A quorum of two-thirds of the committee members is required to hold a meeting, and decisions must be made by a majority vote [10][30] - The committee's resolutions must be documented and communicated to the Board of Directors promptly [39][40] Group 6: Evaluation and Confidentiality - The Nomination Committee has the authority to evaluate the performance of directors and senior management, requiring cooperation from relevant departments [46][47] - Members of the committee are obligated to maintain confidentiality regarding any non-public information they encounter [50]
信雅达: 信雅达科技股份有限公司董事会审计委员会议事规则
Zheng Quan Zhi Xing· 2025-08-26 16:24
Core Points - The article outlines the rules governing the operation of the Audit Committee of Xinyada Technology Co., Ltd, aiming to enhance corporate governance and ensure compliance with relevant laws and regulations [1][2][3] Chapter 1: General Principles - The Audit Committee is a specialized committee under the Board of Directors, responsible for supervising and evaluating internal and external audit work, and ensuring the accuracy of financial reports [1][2] - The company will provide necessary working conditions for the Audit Committee, with the internal audit department designated as the liaison [1][3] Chapter 2: Composition of the Audit Committee - The Audit Committee consists of three or more directors, with a majority being independent directors, and at least one member must be a professional accountant [2][3] - The Chairman of the Audit Committee must be an independent director with accounting expertise [2] Chapter 3: Responsibilities of the Audit Committee - The Audit Committee is responsible for supervising internal and external audit work, reviewing financial information, and ensuring effective internal controls [4][5] - It must approve significant matters such as financial disclosures, hiring or firing external auditors, and changes in accounting policies before submission to the Board [4][5] Chapter 4: Meetings of the Audit Committee - The Audit Committee must hold at least one meeting per quarter, with the ability to convene additional meetings as necessary [21][22] - A quorum requires the presence of at least two-thirds of the members, and decisions must be approved by a majority [23][24] Chapter 5: Information Disclosure - The company is required to disclose the composition and professional background of the Audit Committee members, as well as their performance in the annual report [32][33] - Any significant issues identified by the Audit Committee that meet disclosure standards must be reported promptly [34][35] Chapter 6: Supplementary Provisions - The rules will be executed in accordance with national laws and regulations, and any conflicts will be resolved in favor of the latest legal provisions [37][38]
福蓉科技: 总经理工作细则
Zheng Quan Zhi Xing· 2025-08-26 16:24
第一条 为了规范四川福蓉科技股份公司(以下简称公司)的行为,进一 步完善公司法人治理结构,提高公司总经理的科学决策水平,根据《中华人民共 和国公司法》 第一章 总则 (以下简称《公司法》)及其他有关法律、行政法规、规范性文件和 公司章程的规定,制定本规则。 第二条 公司总经理负责主持公司的日常生产经营和管理工作,组织实施 董事会决议,对董事会负责。 第二章 总经理的任职资格与任免程序 公司违反前款规定聘任的总经理,该聘任无效,总经理在任职期间出现前 款规定情形的,公司董事会应当立即予以解聘。 第五条 公司设总经理一名,由董事会聘任或解聘。董事可受聘兼任总经 理、副总经理或者其他高级管理人员。 第六条 总经理每届任期为三年,连聘可以连任。 第三条 总经理应当具备下列资格: (一)具有较丰富的经济理论知识、管理知识及实践经验,具有较强的经 营管理能力; (二)具有调动员工积极性的领导能力、建立合理的组织机构并协调各种 内外关系和统揽全局的能力; (三)具有一定年限的企业管理或经济工作经历,精通公司所处的行业, 熟悉多种行业的生产经营业务和掌握国家有关政策、法律和法规; (四)诚信勤勉,廉洁奉公,民主公道; (五) ...
浙海德曼: 浙海德曼董事会秘书工作制度(202508)
Zheng Quan Zhi Xing· 2025-08-26 16:23
浙江海德曼智能装备股份有限公司 董事会秘书工作制度 董事会秘书工作制度 第一章 总 则 浙江海德曼智能装备股份有限公司 第二章 董事会秘书的聘任、解聘及任职资格 第六条、董事会秘书由董事长提名,经董事会聘任或解聘。如董事会秘书自 行提出辞去董事会秘书职务的,需经董事会批准后生效。 第七条、董事会秘书应当具备履行职责所必须的财务、管理、法律专业知识, 具有良好的职业道德和个人品德,具备履行职责所必须的工作经验,并取得证券 交易所颁发的董事会秘书资格证书。 《公司法》")等法 律、法规、规范性文件及《浙江海德曼智能装备股份有限公司章程》(以下简称 "公司章程")的相关规定,制定本制度。 第二条、公司设董事会秘书一名,负责公司的信息披露事务。董事会秘书为 公司高级管理人员,应当具备相应任职条件和资格,忠实、勤勉履行职责。 第一条、为进一步规范公司董事会秘书的工作职责和程序,促使董事会秘书 更好地履行职责,根据《中华人民共和国公司法》 第三条、董事会秘书对公司和董事会负责。 (以下简称" 第四条、公司董事会在聘任董事会秘书的同时,可以适时聘任证券事务代表, 协助董事会秘书履行职责。 第五条、公司董事会秘书和证券事务代 ...
诚意药业: 浙江诚意药业股份有限公司总经理工作细则(2025年8月修订)
Zheng Quan Zhi Xing· 2025-08-26 16:23
General Provisions - The purpose of the work guidelines is to promote institutional, standardized, and scientific management of Zhejiang Chengyi Pharmaceutical Co., Ltd. to ensure the correct and reasonable nature of major business decisions [1] - The guidelines apply to the general manager and other senior management personnel, including vice presidents and financial officers [1] Composition and Appointment Procedures of the General Manager Team - The general manager team consists of one general manager, several vice presidents, and one financial officer [2] - The general manager is nominated by the chairman and appointed or dismissed by the board of directors, while vice presidents and financial officers are nominated by the general manager and appointed or dismissed by the board [2] - The term of the general manager team is three years, with the possibility of reappointment [2] Responsibilities and Duties of the General Manager Team - The general manager is responsible for leading the company's overall work and is accountable to the board of directors [3][12] - The financial officer is responsible for leading the financial management work and ensuring compliance with national accounting regulations [5] - The general manager team must adhere to the company's articles of association and fulfill their duties faithfully to protect the company's interests [6][16] Reporting System - The general manager must report the company's operational status to the board of directors quarterly and must ensure the authenticity of the reports [12][33] - In case of significant incidents or emergencies, the general manager and other senior management must report to the chairman immediately [12][35] Performance Evaluation and Incentive Mechanism - The performance evaluation of the general manager and other senior management is conducted by the board's remuneration and assessment committee [36] - The compensation of the general manager team is linked to the company's performance and individual achievements [37]
美诺华: 宁波美诺华药业股份有限公司第五届董事会第十六次会议决议公告
Zheng Quan Zhi Xing· 2025-08-26 16:23
宁波美诺华药业股份有限公司(以下简称"公司")于 2025 年 8 月 15 日以 书面、电子邮件等方式向公司全体董事发出召开第五届董事会第十六次会议的通 知和会议材料。2025 年 8 月 26 日,公司第五届董事会第十六次会议在公司会议 室以现场结合通讯表决方式召开。本次会议由姚成志先生主持,会议应出席董事 集和召开符合《中华人民共和国公司法》等有关法律法规及《公司章程》《董事 会议事规则》的规定。 证券代码:603538 证券简称:美诺华 公告编号:2025-091 转债代码:113618 转债简称:美诺转债 宁波美诺华药业股份有限公司 第五届董事会第十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 二、董事会会议审议情况 (一)审议通过《2025 年半年度报告及摘要》 具体内容详见公司于上海证券交易所网(www.sse.com.cn)等指定信息披露 媒体同日披露的《2025 年半年度报告》及《2025 年半年度报告摘要》。 本议案已经公司董事会审计委员会全体成员审议通过,并同意 ...
ST智知: 新智认知数字科技股份有限公司第五届董事会第二十次会议决议公告
Zheng Quan Zhi Xing· 2025-08-26 16:23
证券代码:603869 证券简称:ST 智知 公告编号:临 2025-028 新智认知数字科技股份有限公司 第五届董事会第二十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 新智认知数字科技股份有限公司(以下简称"公司")第五届董事会第二十 次会议(以下简称"会议")通知于 2025 年 8 月 15 日以邮件的形式发出,会议 按照预定时间于 2025 年 8 月 25 日以通讯表决的方式召开。本次会议应到董事 9 名,实际出席董事 9 名,公司全体监事及高级管理人员列席了本次会议。本次会 议由公司董事长史玉江先生主持。本次会议的召开和表决程序符合《中华人民共 和国公司法》等法律、行政法规、规范性文件和《新智认知数字科技股份有限公 司章程》的有关规定,会议决议合法有效。 经与会董事充分讨论,会议审议并通过了如下议案: 一、审议通过了《新智认知 2025 年半年度报告》及摘要。 该议案在提交董事会审议前已经公司第五届董事会审计委员会 2025 年第四 次会议审议通过。具体内容详见同日披露于上海证券交易所网站的《新 ...
华达新材: 浙江华达新型材料股份有限公司第四届董事会第七次会议决议公告
Zheng Quan Zhi Xing· 2025-08-26 16:23
证券代码:605158 证券简称:华达新材 公告编号:2025-029 浙江华达新型材料股份有限公司 第四届董事会第七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 浙江华达新型材料股份有限公司(以下简称"公司")第四届董事会第七次 会议通知和调整会议时间的通知分别于 2025 年 8 月 18 日、2025 年 8 月 24 日, 以电子邮件及通讯方式送达全体董事,会议于 2025 年 8 月 26 日在公司会议室, 以现场会议的方式召开。本次会议应出席董事 7 人,实际出席董事 7 人,公司监 事和高级管理人员列席本次会议。本次会议由董事长邵明祥先生主持。本次会议 符合《公司法》《公司章程》和《董事会议事规则》的有关规定,会议的召集、 召开合法有效。 二、董事会会议审议情况 (一)审议通过《关于<2025 年半年度报告全文及摘要>的议案》 公司按照相关规定编制了《2025 年半年度报告》及摘要。 具体内容详见公司同日刊登于上海证券交易所网站(www.sse.com.cn)及公 司指定 ...
润达医疗: 董事会决议公告
Zheng Quan Zhi Xing· 2025-08-26 16:23
Group 1 - The board of directors of Shanghai RunDa Medical Technology Co., Ltd. held its 24th meeting on August 26, 2025, with all 11 directors present, including independent directors attending via communication [1] - The meeting approved the 2025 semi-annual report and its summary, with a unanimous vote of 11 in favor [2] - A special report on the storage and actual use of raised funds for the first half of 2025 was also approved, reflecting accurate management of the funds [3] Group 2 - The board approved an increase in the estimated amount for daily related party transactions for 2025 due to business development needs, with 9 votes in favor and 2 abstentions [4] - The board decided to cancel the supervisory board and revise the company's articles of association and related systems, transferring the supervisory powers to the audit committee [5] - The board proposed to reappoint Zhonghua Accounting Firm as the financial audit and internal control audit institution for 2025, with unanimous approval [5] - A resolution to convene the first extraordinary general meeting of shareholders in 2025 was also passed, with all directors voting in favor [6]
*ST华微: 吉林华微电子股份有限公司第九届监事会第六次会议决议公告
Zheng Quan Zhi Xing· 2025-08-26 16:23
证券代码:600360 证券简称:*ST 华微 公告编号:2024-069 吉林华微电子股份有限公司 第九届监事会第六次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏, 并对其内容的真实性、准确性和完整性承担法律责任。 吉林华微电子股份有限公司(以下简称"公司")第九届监事会第六次会议于 2025 年 8 月 26 日在公司本部会议室召开,应到监事 3 名,实到 3 名,符合《公司章程》 规定的法定人数,公司高级管理人员列席了会议。会议通知于 2025 年 8 月 21 日分 别以送达、发送电子邮件及电话通知的方式通知了各位监事,本次会议的通知和召 开符合《公司法》与《公司章程》的规定。会议由监事会召集人禹彤女士主持。经 与会监事审议,通过了如下议案: 一、审议《吉林华微电子股份有限公司 2025 年半年度报告全文及其摘要的议案》 表决结果:同意 3 票;反对 0 票;弃权 0 票。 公司监事会对公司董事会编制的 2025 年半年度报告审核意见如下: 内部管理制度的各项规定; 定,所包含的信息能从各个方面真实地反映出公司 2025 年上半年的经营管理和财务 状况; ...